• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状疾病的检测和治疗时机。

Timing of testing and treatment for asymptomatic diseases.

机构信息

State University of New York - Binghamton, School of Management, P.O. Box 6000, Binghamton, NY 13902, USA.

出版信息

Math Biosci. 2010 Jul;226(1):28-37. doi: 10.1016/j.mbs.2010.03.007. Epub 2010 Mar 31.

DOI:10.1016/j.mbs.2010.03.007
PMID:20361985
Abstract

Many papers in the medical literature analyze the cost-effectiveness of screening for diseases by comparing a limited number of a priori testing policies under estimated problem parameters. However, this may be insufficient to determine the best timing of the tests or incorporate changes over time. In this paper, we develop and solve a Markov Decision Process (MDP) model for a simple class of asymptomatic diseases in order to provide the building blocks for analysis of a more general class of diseases. We provide a computationally efficient method for determining a cost-effective dynamic intervention strategy that takes into account (i) the results of the previous test for each individual and (ii) the change in the individual's behavior based on awareness of the disease. We demonstrate the usefulness of the approach by applying the results to screening decisions for Hepatitis C (HCV) using medical data, and compare our findings to current HCV screening recommendations.

摘要

许多医学文献中的论文通过比较估计问题参数下有限数量的先验测试策略来分析疾病筛查的成本效益。然而,这可能不足以确定测试的最佳时间或纳入随时间的变化。在本文中,我们开发并解决了一个简单类无症状疾病的马尔可夫决策过程(MDP)模型,以便为更一般类疾病的分析提供构建模块。我们提供了一种计算有效的方法来确定一种具有成本效益的动态干预策略,该策略考虑了(i)每个人的前一次测试结果和(ii)基于对疾病的认识而改变的个人行为。我们通过使用医疗数据对丙型肝炎(HCV)的筛查决策应用结果来证明该方法的有用性,并将我们的发现与当前的 HCV 筛查建议进行比较。

相似文献

1
Timing of testing and treatment for asymptomatic diseases.无症状疾病的检测和治疗时机。
Math Biosci. 2010 Jul;226(1):28-37. doi: 10.1016/j.mbs.2010.03.007. Epub 2010 Mar 31.
2
Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.孕期丙型肝炎病毒常规筛查:一项成本效益分析。
Am J Obstet Gynecol. 2005 Apr;192(4):1153-61. doi: 10.1016/j.ajog.2004.10.600.
3
Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.丙型肝炎病毒感染筛查的长期有效性和成本效益
Eur J Public Health. 2009 Jun;19(3):245-53. doi: 10.1093/eurpub/ckp001. Epub 2009 Feb 5.
4
[Medical and economic evaluation of donated blood screening for hepatitis C and non-A, non-B, non-C hepatitis].[丙型肝炎及非甲、非乙、非丙型肝炎献血筛查的医学与经济学评估]
Rev Epidemiol Sante Publique. 1996 Jan;44(1):66-79.
5
Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective.根据个体基线前列腺特异性抗原值确定重新筛查间隔的前列腺癌筛查策略具有成本效益。
Eur J Surg Oncol. 2007 Aug;33(6):783-9. doi: 10.1016/j.ejso.2007.02.015. Epub 2007 Apr 3.
6
A social cost-benefit criterion for evaluating Voluntary Counseling and Testing with an application to Tanzania.评估自愿咨询检测的社会成本效益标准及其在坦桑尼亚的应用。
Health Econ. 2010 Feb;19(2):154-72. doi: 10.1002/hec.1457.
7
Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program.丙型肝炎感染风险分析:谁应接受筛查?基于国家肝炎监测计划的多种筛查策略比较。
Am J Gastroenterol. 1998 Apr;93(4):591-6. doi: 10.1111/j.1572-0241.1998.170_b.x.
8
Who should be screened for HIV infection? A cost-effectiveness analysis.哪些人应该接受HIV感染筛查?一项成本效益分析。
Arch Intern Med. 1993 May 10;153(9):1107-16.
9
Cost-effectiveness of screening for hereditary hemochromatosis.遗传性血色素沉着症筛查的成本效益
Arch Intern Med. 1994 Apr 11;154(7):769-76.
10
Evaluation of an antimicrobial resistance monitoring program for Campylobacter in poultry by simulation.通过模拟评估家禽弯曲杆菌抗菌药物耐药性监测项目
Prev Vet Med. 2005 Aug 12;70(1-2):29-43. doi: 10.1016/j.prevetmed.2005.02.017. Epub 2005 Apr 12.

引用本文的文献

1
Population-level intervention and information collection in dynamic healthcare policy.人群干预和动态医疗政策中的信息收集。
Health Care Manag Sci. 2018 Dec;21(4):604-631. doi: 10.1007/s10729-017-9415-5. Epub 2017 Sep 8.